{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-045459","form_type":"8-K/A","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2023-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.161573+00:00","generated_at":"2026-06-07T10:49:29.101716+00:00","sec_items":["3.03","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Semper Paratus shareholders approve extension to Sep 2024; $9.7M redeemed","bullets":["Shareholders approved extension of deadline to September 15, 2024 via one 3-month and six 1-month extensions.","880,873 Class A shares redeemed at ~$11.02/share for aggregate ~$9.7 million.","Trust account balance after redemptions and $67,500 payment is ~$16.5 million.","First extension to March 15, 2024 triggered by $67,500 deposit into trust.","Amendment to charter filed with Cayman Registrar to allow the extensions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-045459","json":"https://secwatch.observer/filing/0001493152-23-045459.json","markdown":"https://secwatch.observer/filing/0001493152-23-045459.md","text":"https://secwatch.observer/filing/0001493152-23-045459.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/0001493152-23-045459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T10:49:29.101716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e40975ce0f1c430d120b7a2d892f8376de0eea8","claim":"Tevogen Bio Holdings Inc.: Adopted and filed an amended charter to extend the deadline for an initial business combination to September 15, 2024, with a series of extension mechanisms and required deposits into the trust account (effective 2023-12-19).","evidence_excerpt":"At the Extraordinary General Meeting, the Shareholders approved the Extension Amendment Proposal for the Company to adopt and file the Amended Charter, which the Company promptly filed following the Shareholders’ approval.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/0001493152-23-045459-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-12-19"}],"fact_type":"governance_change"},{"claim_id":"ca357089adf78639a554f3222e7f3af2b2dc2909","claim":"Tevogen Bio Holdings Inc. shareholders approved Extension Amendment Proposal.","evidence_excerpt":"The Shareholders approved the Extension Amendment Proposal. The following is a tabulation of the voting results: Ordinary Shares: Votes For Votes Against Abstentions Broker Non-Votes 14,359,632 5,967 0 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/0001493152-23-045459-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}